Literature DB >> 21769320

Adrenal adenomatoid tumor in a patient with human immunodeficiency virus.

Roy Phitayakorn1, Gregory Maclennan, Peter Sadow, Scott Wilhelm.   

Abstract

We present the clinical course of a patient with human immunodeficiency virus and an adrenal adenomatoid tumor (AAT). We describe the clinical course and laboratory, radiographic, and microscopic findings of a patient with human immunodeficiency virus (HIV) and an adenomatoid tumor of the right adrenal gland. A review of the literature was also done via electronic searches through PubMed for articles from 1965 to 2008 that contained the following search terms, adenomatoid tumor limited to the English language only. A 22 year-old African-American male with HIV was incidentally found to have a hypermetabolic right adrenal mass. The patient underwent laparoscopic adrenalectomy and the mass had morphological and immunohistochemical features that were consistent with an AAT. A review of the medical literature reveals that almost all cases of AAT were in male patients (96%) with a mean age of 41±11 years (range=22-64) with no significant difference in laterality (right side=46%, left side=50%, unknown=4%). AAT have an average size of 4.2±3.5 cm (range=0.5-14.3 cm). Pre-operative imaging studies do not appear to be able to reliably distinguish AAT from other types of adrenocortical tumors. For reasons that require further research, AAT typically occur in male patients and may be associated with immunosuppression. AAT can be safely removed laparoscopically with no evidence of long-term recurrence even with tumor extension beyond the adrenal capsule.

Entities:  

Keywords:  adenomatoid tumor; adrenal; human immunodeficiency virus.

Year:  2011        PMID: 21769320      PMCID: PMC3132125          DOI: 10.4081/rt.2011.e21

Source DB:  PubMed          Journal:  Rare Tumors        ISSN: 2036-3605


Introduction

Adenomatoid tumors most commonly occur in the genital tract including the epididymis, uterus, or fallopian tube.[1] Interestingly, these tumors have also been reported to occur in the adrenal gland.[1-6] Adrenal adenomatoid tumors are derived from mesothelial cells from mesothelial rests within the adrenal gland. These rests are likely present due to the close embryological relationship between the adrenal glands and the Mullerian tract.[6-7] This report represents the 29th case of an adrenal adenomatoid tumor in the literature, but is only the second case described in a patient with human immunodeficiency virus and the first case in which positron emission tomographic scanning was used as part of the diagnostic work-up.

Materials and Methods

We describe the clinical course, laboratory, radiographic, and microscopic findings of a patient with human immunodeficiency virus and an adenomatoid tumor of the right adrenal gland. A review of the literature was also done via electronic searches through PubMed for articles from 1965 to 2008 that contained the following search terms, adenomatoid tumor limited to the English language only. All articles that contained reported cases of adenomatoid tumor were analyzed. Pertinent references from these articles were reviewed and synthesized. This cycle continued until it was felt that a complete listing of all published cases of adenomatoid tumors in the English language was obtained. This study was approved by the Institutional Review Board at University Hospitals of Cleveland.

Results

Report of a case

AH is a 22 year-old African-American male with a past medical history of human immunodeficiency virus on HAART (Highly Active Anti-Retroviral Therapy) who was noted to have an incidental adrenal mass on computed tomography of the chest done as a follow-up study for mediastinal lymphadenopathy. No previous adrenal masses were noted on previous computed tomographic imaging. The patient denied any symptoms of palpitations, diaphoresis, flushing, or uncontrolled high blood pressure. He subsequently had a magnetic resonance imaging scan to further characterize the adrenal mass. It was a right adrenal mass that measured 2.7 by 1.6 by 2.3 cm in size with atypical enhancement patterns with gadolinium contrast. The patient underwent a complete adrenal hormonal work-up. His 24-hour urine catecholamines, serum aldosterone, and plasma renin activity were all normal. Serum cortisol level was mildly elevated, but his urinary cortisol level was normal. Prior to surgical referral, the patient also underwent a follow-up positron emission tomographic scan which demonstrated increased uptake of 3.4 SUV. Based on the above findings, the differential diagnosis included a non-functioning adrenal adenoma or malignancy. The patient underwent a laparoscopic right adrenalectomy with no post-operative complications on follow-up examination seven months later.

Pathologic findings

On gross examination, the adrenal gland was 5.5 by 3.0 by 1.0 cm in size with a well-circumscribed, firm, tan-gray cortical mass that measured 2.5 by 2.5 by 1.0 cm. No areas of necrosis or hemorrhage were identified in the mass. On light microscopy examination, the adrenal mass was composed of epithelioid cells forming nests, cords, and tubules. There were no areas of necrosis, mitotic activity, or significant atypia. On immmunohistochemical examination, the cells in the adrenal mass were positive for calretinin and cytokeratins (AE1/3 and CAM 5.2) and negative for CD31, CD34, and Factor VIII. These morphological and immunohistochemical features were consistent with an adenomatoid tumor (Figures 1–3).
Figure 1

The tissue at far right in this image is normal adrenal cortical tissue. The native adrenal tissue is replaced or extensively infiltrated by tumor cells forming small solid nests as well as anastomosing channels and tubules of variable size and shape.

Figure 3

Immunostain for calretinin highlights the tumor cells, in keeping with their mesothelial derivation.

The tissue at far right in this image is normal adrenal cortical tissue. The native adrenal tissue is replaced or extensively infiltrated by tumor cells forming small solid nests as well as anastomosing channels and tubules of variable size and shape. Lesional cells range from plump epithelioid cells to flattened cells resembling endothelial cells, and many exhibit prominent vacuolization, to an extent that may mimic a signet-ring appearance with apparent intracytoplasmic lumina. They do not exhibit nuclear pleomorphism, necrosis or mitotic activity. Immunostain for calretinin highlights the tumor cells, in keeping with their mesothelial derivation.

Literature review

As illustrated in Table 1 and Table 2, there have been 29 reported cases of adenomatoid tumors of the adrenal gland in the recent English-language medical literature.[1-19] Almost all of these cases were in male patients (97%) with a mean age of 40Literature Review10 years (range=22–64). The laterality of these tumors is approximately 14 (48%) tumors on the right side and 14 (48%) tumors on the left side (laterality was unknown in one patient) with an average size of 4.6±4.0 cm (range=0.5–16.7 cm). Many of these tumors were either discovered as part of an autopsy or incidentally found as part of a diagnostic work-up for various symptoms including: painless hematuria, hypertension, abdominal pain, and Cushing's syndrome. Various imaging modalities were used including computed tomography (n=18), magnetic resonance imaging (n=6), ultrasound (n=3), and positron emission tomography (n=1). Interestingly, eight (31%) patients had adenomatoid tumors that extended into the periadrenal adipose tissue or the adrenal gland capsule. However, no recurrences have been reported with a median follow-up time of 33 months (range=3 to 177 months).
Table 1

clinical data from review of the medical literature

#AuthorGenderAgeSide of massSize of mass (cm)Clinical dataCT SscanMRIU/SHormonal functionResectionFollow-up
1Evans et al.MALE36LEFT11Painless hematuriaYNNAll WNLOPEN8 months
2Simpson et al.MALE44LEFTNot statedHTNYNNElevated urinaryhomovanillic acid levelOPEN177 months
3Travis et al.MALE24LEFT1.1Cushing syndromeNot statedNot statedNot statedNot statedOPENPatient expired 6months later secondaryto massive pulmonarycarcinoid metastases
4Raaf et al.MALE49RIGHT1.3IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy
5Raaf et al.MALE57LEFT3.8IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy
6Raaf et al.FEMALE50RIGHT0.5IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy
7Raaf et al.MALE40LEFT6IncidentalYNNNot statedNot statedNot stated
8Angeles-Angeles et al.MALE34RIGHT3AIDSAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy
9Gasque et al.MALE28RIGHT9Abdominal painNYYAll WNLNot stated16 months
10Glatz et al.MALE54LEFT6.5Sudden epigastic painYNNNot statedNot statedNot stated
11Chung-Park et al.MALE51RIGHT3HTNYNNLow plasma renninactivity and high aldosteroneto plasma renin ratioLAPNot stated
12Isotalo et al.MALE37LEFT3.1IncidentalNot statedNot statedNot statedNot statedNot stated40 months
13Isotalo et al.MALE31RIGHT3.2IncidentalNot statedNot statedNot statedNot statedNot statedNot stated
14Isotalo et al.MALE31Not stated3.5SyncopeNot statedNot statedNot statedNot statedNot stated50 months
15Isotalo et al.MALE64LEFT1.2IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy
16Kim and RoMALE33LEFT1.7HTNYNNNot statedNot statedNot stated
17Denicol et al.MALE42LEFT14.3HTNYNYAll WNLOPEN3 years
18Garg et al.MALE46RIGHT11Right flank painYNYNot doneOPENNot stated
19Garg et al.MALE33LEFT1.7HTNYNNNot doneOPENNot stated
20Garg et al.MALE33RIGHT4.2IncidentalYYNAll WNLOPEN1 year
21Varkarakis et al.MALE54RIGHT3.6IncidentalYYNElevated urinary homovanillic acid levelLAP1 year
22Hamamatsu et al.MALE30LEFT3IncidentalAutopsyAutopsyAutopsyAutopsyAutopsyFound at autopsy
23Timonera et al.MALE47RIGHT5.6IncidentalYYNAll WNLLAPNot stated
24MALE52RIGHT2HTNYYNAll WNLLAP
25Fan et al.MALE42LEFT2.5HTNYNNAll WNLLAPNot stated
26Hoffman et al.MALE26RIGHT1.5IncidentalYNNNot doneOPENNot stated
27Bisceglia et al.MALE39RIGHT5.5IncidentalYNNAll WNLOPENNot stated
28Liu et al.MALE44LEFT16.7IncidentalYNNAll WNLOPEN3 months
29Phitayakorn et al.MALE22RIGHT2.5IncidentalYYNElevated serum cortisolLAP7 months
Table 2

Pathological data from review of the medical literature.

# AuthorTumor characteristicsTumor extensionHistochemistryElectron microscopy
1 Evans et al.Tan, smooth with cystic spacesNo extensionNot statedNumerous slender microvilli,desmoslome-like intracellular junctions,intracytoplasmic tonofilaments
2 Simpsonet al.Fleshy, gray, solid, cysticExtension into peri-adrenaladipose tissuePositive for antihuman cytokeratin,but negative for carcinoembryonic antigen;No glycogen or mucin contentNot done
3 Travis et al.Pale, white, and solidExtension into cortex and periadrenaladipose tissueStrongly positive for keratin (AE1/AE3)and vimentin; Weakly positive for epithelialmembrane antigenTortuous microvilli with a moderateamount of tonofilaments
4 Raaf et al.White and solidNo extensionReacted with MAK-6 and AE1/AE3;Positive staining for vimentinLong, thin, bushy microvilli with well-developed desmosomes, basal laminae,and cytoplasmic tonofilaments
5 Raaf et al.White, solid, firm, and smoothNo extensionReacted with MAK-6 and AE1/AE3;Positive staining for vimentinNot done
6 Raaf et al.White, firm and smoothNo extensionNot statedNot done
7 Raaf et al.White, predominantly cysticNo extensionReacted with MAK-6 and AE1/AE3;Positive staining for vimentinlaminae, and cytoplasmic tonofilamentsLong, thin, bushy microvilliwith well-developed desmosomes, basal
8 Angeles-Angeles et al.Ill-defined, white-yellowish, and firm noduleNo extensionStained positive for low molecular weightcytokeratin CKAE-3 and weakly for vimentinNot done
9 Gasque et al.Grayish with pseudocystNo extensionStains positive for cytokeratin (CAM 5.2)Not done
10 Glatz et al.Pale-yellow, spongy, cysticNo extensionStrongly positive for keratin (Cam 5.2, Lu-5)and calretinin; Weakly positivefor thrombomodulin.Negative staining for CEA, MOC-31, BerEP4,and CD34.Long and slender microvilliLong and slender microvilliand abundant desmosomes alongluminal surface with bundlesof tonofibrils in the cytoplasm
11 Chung-Park et al.Pale-yellow, solid, and firmExtension into adrenal cortxPositive for cytokeratin and calretinin,but negative for synaptophysin,chromogranin,factor VIII, CD34, and S-100.Long, busy microvilli withintracytoplasmic tonofilaments,and intercellular desmosomes
12 Isotalo et al.Solitary and poorlycircumscribedExtension into peri-adrenaladipose tissueStrongly positive for calretinin, cytokeratins(AE1/AE3, CAM 5.2, CK7) and vimentin.Weakly positive for CK5/CK6.Negative for CD15, CD31, CD34, CK20,MOC31, and p-CEA.Not done
13 Isotalo et al.Extension into adrenal gland capsuleNot done
14 Isotalo et al.Extension into adrenal gland capsuleNot done
15 Isotalo et al.Extension into peri-adrenal adipose tissueNot done
16 Kim and RoSmooth, grayish, white and firmwith cystic spacesNo extensionStained positive for cytokeratinand calretininDesmosomes. Cytomplasmic fibrillarnetworks, and numerous long, bushy,microvilli on luminal surfaces
17 Denicol et al.Multicystic, yellow, opaqueNo extensionStains positive for AE1, AE3, and vimentinNot done
18 Garg et al.Fibrous wall with an intramuralwell-demarcated tumorcontaining adipose tissue andlymphoidNo extensionStains positive for calretinin and focal weakstaining for cytokeratin 5/6Numerouslong, bushy, and slender microvilli
19 Garg et al.Aggregates, areas ofmucin production, cells witha signet ringlike appearanceNo extensionStains positive for calretininand strong staining for cytokeratin 5/6Numerouslong, bushy, and slender microvilli
20 Garg et al.No extensionSains positive for calretininNot done
21 Varkarakis et al.Tan nodular with sitesof heterotopic ossificationNo extensionStains positive for calretininNot done
22 Hamamatsu et al.White, solid, well-circumscribed,and smoothNo extensionStained positive for calretinin, D2–40,vimentin, and cytokeratins(AE1/AE3, OV-TL 12/30, CAM 5.2,and MNF116Not done
23 Timonera et al.Well-circumscribed, solid,No extensionwith variegated yellowand tan cut surfaceStrongly positive for D2–40 and calretininNot doneand weak reactivity for cytokeratin 5/6
24 Timonera et al.Well circumscribed,heterogeneous cystic and solidmass with hemorrhagic areas
25 Fan et al.Ill-defined edge, smooth,greyish-white, firm, withno hemorrhage or necrosisFocal infiltration of adrenalcortex and medullaPositive for cytokeratin 7,calretinin, vimentin,antimesothelial cell ab,and epithelial membrane antigenNot done
26 Hoffman et al.Grey-whitish pattern of small cysticnodules with trabeculaeNo extensionPositive for cytokeratin and calretinin,but negative for CD31, CD34, and CD56Not done
27 Bisceglia et al.Cystic, gray to pale yellowish with slightmural thickening and short endoluminalpapillationsNo extensionPositive to cytokeratins and calretinin,but negative to endothelial markersNumerous small microvilli(coelomic or mesothelial type)
28 Liu et al.Ill-circumscribed multilocular cystictumor with tan wall with no hemorrhageor necrosis, cyst fluid was clear-yellowEnveloped around the ipsilateralrenal artery and veinPositive for calretinin and epithelialmembrane antigen,but negative for endothelial markersNot done
29 Phitayakorn et al.Well circumscribed, tan-graycortical massNo extensionStained positive for calretinin and cytokeratins(AE1/AE3 and CAM 5.2), and stainednegative for CD31, CD34, and factor VIII.Not done
In terms of tumor color, these tumors have been described as being white, tan, fleshy, pale-yellow, opaque, and grayish. In terms of tumor consistency, however, these tumors have been described as being firm, smooth, cystic, solid, and well-circumscribed. Other histopathological characteristics have been noted in adenomatoid tumors including: heterotopic ossification, lymphoid aggregates, sites of mucin production, and cells with a signet ring-like appearance. Adenomatoid tumors have been found to stain positive with a wide variety of agents including: vimentin, calretinin, cytokeratins (CAM 5.2, CKAE1, and CKAE3), MAK-6, D2–40, OV-TL 12/30, and MNF 116. A few studies have examined adenomatoid tumors using electron microscopy and found various features including: numerous long, thin, bushy microvilli with well developed desmosomes, basal laminae, and cytoplasmic fibrillar networks.

Discussion

Patients with human immunodeficiency virus (HIV) frequently present with a number of associated neoplasms, often as a result of their immunosuppression. It is very unusual for HIV-positive patients to present with adrenal gland neoplasms other than Kaposi's sarcoma or lymphoma. HIV-positive patients may also present with infectious etiologies that may present as an adrenal mass, including cytomegalovirus necrotizing adrenalitis, mycobacterium, cryptococcus, or other fungal infections.[20,21] This case represents only the second reported case of an adenomatoid tumor in a patient with HIV. However, it is unknown how many other patients with reported adrenal adenomatoid tumors were tested for HIV. It is possible that the incidence of adrenal adenomatoid tumors in patients with HIV may increase as a consequence of anti-retroviral therapies or chronic immunosuppression. Although the first adenomatoid tumor was described in 1945, adrenal adenomatoid tumors were not well described until the late 1980's.[22] This result may be due to the increasing use of diagnostic computed tomographic imaging in detecting adrenal incidentalomas. This case also highlights an important caveat in that imaging techniques such as computed tomography cannot reliably distinguish adrenal adenomatoid tumors from other adrenocortical tumors.[5] Magnetic resonance imaging of the adrenal adenomatoid tumor in this patient was more consistent with a functional adrenal tumor. Another study that used MRI in a patient with an adrenal adenomatoid noted that the tumor was mainly solid with cystic peripheral portions, and that the solid areas were homogenously isointense to the spleen on all images.[5] In this particular case, the use of a positron-emission tomographic (PET) scan was also not helpful in pre-operatively diagnosing an adrenal adenomatoid tumor. In fact, the level of 18F-FDG uptake of 3.4 SUV was in the range of malignant adrenal lesions.[23] Finally, this case emphasizes that although adrenal adenomatoid tumors have been described in the past as extending into the perirenal adipose tissue, the clinical behavior is definitely benign.[10] Adrenal adenomatoid tumors may be misclassified as lymphangiomas or adenocarcinomas because of infiltrative borders into the adrenal capsule or periadrenal adipose tissue.[24] These tumors can be reliably distinguished from adrenal adenocarcinoma as adenomatoid tumors stain positive for keratin and do not produce mucin. Based on Table 1, local resection limited to the adrenal gland itself without any specific post-operative surveillance protocol appears to be sufficient treatment of adrenal adenomatoid tumors. Laparoscopic adrenalectomy which is the current gold-standard for the surgical resection of adrenal tumors can be safely employed in the case of adrenal adenomatoid tumors.
  24 in total

1.  Papillary adenomatoid tumour of the adrenal gland.

Authors:  K Glatz; W Wegmann
Journal:  Histopathology       Date:  2000-10       Impact factor: 5.087

Review 2.  Adrenal imaging.

Authors:  Michael A Blake; Carmel G Cronin; Giles W Boland
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

3.  Adenomatoid tumour of the left adrenal gland with concurrent left nephrolithiasis and left kidney cyst.

Authors:  Song-Qing Fan; Yi Jiang; Duo Li; Qi-You Wei
Journal:  Pathology       Date:  2005-10       Impact factor: 5.306

4.  Adenomatoid tumor of the adrenal gland mimicking an echinococcus cyst of the liver--a case report.

Authors:  Martin Hoffmann; Süleyman Yedibela; Arno Dimmler; Werner Hohenberger; Thomas Meyer
Journal:  Int J Surg       Date:  2006-08-14       Impact factor: 6.071

5.  Adenomatoid tumor of the adrenal gland with ultrastructural and immunohistochemical demonstration of a mesothelial origin.

Authors:  W D Travis; E E Lack; N Azumi; M Tsokos; J Norton
Journal:  Arch Pathol Lab Med       Date:  1990-07       Impact factor: 5.534

6.  Adenomatoid tumor of the adrenal gland: case report with immunohistochemical study.

Authors:  Akihiko Hamamatsu; Tomio Arai; Masao Iwamoto; Tomoyuki Kato; Motoji Sawabe
Journal:  Pathol Int       Date:  2005-10       Impact factor: 2.534

7.  Adenomatoid tumor of supra-renal gland.

Authors:  Nancy T Denicol; Fabrício R Lemos; Walter J Koff
Journal:  Int Braz J Urol       Date:  2004 Jul-Aug       Impact factor: 1.541

Review 8.  Cystic lymphangioma-like adenomatoid tumor of the adrenal gland: Case presentation and review of the literature.

Authors:  Michele Bisceglia; Illuminato Carosi; Alfredo Scillitani; Gianandrea Pasquinelli
Journal:  Adv Anat Pathol       Date:  2009-11       Impact factor: 3.875

9.  Adenomatoid Tumor of the Right Adrenal Gland in a Patient with AIDS.

Authors:  Arturo Angeles-Angeles; Edgardo Reyes; Luis Munoz-Fernandez; Peter Angritt
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

10.  Composite adenomatoid tumor and myelolipoma of adrenal gland: report of 2 cases.

Authors:  Elizabeth R Timonera; Maria Emilia Paiva; Jose Manuel Lopes; Catarina Eloy; Theodore van der Kwast; Sylvia L Asa
Journal:  Arch Pathol Lab Med       Date:  2008-02       Impact factor: 5.534

View more
  6 in total

1.  An Unusual Adrenal Cortical Nodule: Composite Adrenal Cortical Adenoma and Adenomatoid Tumor.

Authors:  Orhun Cig Taskin; Hasan Gucer; Ozgur Mete
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 2.  Adenomatoid tumours of the gastrointestinal tract - a case-series and review of the literature.

Authors:  Erika Hissong; Rondell P Graham; Kwun Wah Wen; Lindsay Alpert; Jiaqi Shi; Laura W Lamps
Journal:  Histopathology       Date:  2021-10-07       Impact factor: 7.778

3.  Mesothelial derived adenomatoid tumour in a location devoid of mesothelium: adrenal adenomatoid tumour.

Authors:  Yeşim Sağlıcan; Neslihan Kurtulmus; Fatih Tunca; Erdoğan Süleyman
Journal:  BMJ Case Rep       Date:  2015-08-04

Review 4.  Cystic lymphangioma-like adenomatoid tumor of the adrenal gland: report of a rare case and review of the literature.

Authors:  Ming Zhao; Changshui Li; Jiangjiang Zheng; Minghui Yan; Ke Sun; Zhaoming Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

5.  Renal transplantation-related risk factors for the development of uterine adenomatoid tumors.

Authors:  Teruyuki Mizutani; Osamu Yamamuro; Noriko Kato; Kazumasa Hayashi; Junya Chaya; Norihiko Goto; Toyonori Tsuzuki
Journal:  Gynecol Oncol Rep       Date:  2016-05-11

Review 6.  Adenomatoid Tumor of the Adrenal Gland: Report of Two Cases and Review of the Literature.

Authors:  Jiexia Guan; Chang Zhao; Hengming Li; Wenjing Zhang; Weizhen Lin; Luying Tang; Jianning Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.